| Product Code: ETC7222726 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Malaria Vaccine Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Malaria Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 France Malaria Vaccine Market - Industry Life Cycle |
3.4 France Malaria Vaccine Market - Porter's Five Forces |
3.5 France Malaria Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 France Malaria Vaccine Market Revenues & Volume Share, By Agent, 2021 & 2031F |
3.7 France Malaria Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 France Malaria Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 France Malaria Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about malaria prevention and vaccination |
4.2.2 Growing investment in research and development for malaria vaccines |
4.2.3 Government initiatives and funding to combat malaria in France |
4.3 Market Restraints |
4.3.1 Regulatory challenges in vaccine development and approval processes |
4.3.2 Limited accessibility and affordability of vaccines in certain regions of France |
5 France Malaria Vaccine Market Trends |
6 France Malaria Vaccine Market, By Types |
6.1 France Malaria Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 France Malaria Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 France Malaria Vaccine Market Revenues & Volume, By Pre-Erythrocytic Vaccine, 2021- 2031F |
6.1.4 France Malaria Vaccine Market Revenues & Volume, By Erythrocytic Vaccine, 2021- 2031F |
6.1.5 France Malaria Vaccine Market Revenues & Volume, By Multi-Antigen Vaccine, 2021- 2031F |
6.2 France Malaria Vaccine Market, By Agent |
6.2.1 Overview and Analysis |
6.2.2 France Malaria Vaccine Market Revenues & Volume, By Plasmodium Falciparum, 2021- 2031F |
6.2.3 France Malaria Vaccine Market Revenues & Volume, By Plasmodium Vivax, 2021- 2031F |
6.2.4 France Malaria Vaccine Market Revenues & Volume, By Anopheles Species, 2021- 2031F |
6.3 France Malaria Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 France Malaria Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.3 France Malaria Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.4 France Malaria Vaccine Market Revenues & Volume, By Intradermal, 2021- 2031F |
6.4 France Malaria Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 France Malaria Vaccine Market Revenues & Volume, By NGO/Non-Profit Organization, 2021- 2031F |
6.4.3 France Malaria Vaccine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.4 France Malaria Vaccine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.5 France Malaria Vaccine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 France Malaria Vaccine Market Import-Export Trade Statistics |
7.1 France Malaria Vaccine Market Export to Major Countries |
7.2 France Malaria Vaccine Market Imports from Major Countries |
8 France Malaria Vaccine Market Key Performance Indicators |
8.1 Number of clinical trials conducted for malaria vaccines in France |
8.2 Percentage increase in government funding for malaria prevention programs |
8.3 Adoption rate of malaria vaccination among high-risk populations in France |
9 France Malaria Vaccine Market - Opportunity Assessment |
9.1 France Malaria Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 France Malaria Vaccine Market Opportunity Assessment, By Agent, 2021 & 2031F |
9.3 France Malaria Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 France Malaria Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 France Malaria Vaccine Market - Competitive Landscape |
10.1 France Malaria Vaccine Market Revenue Share, By Companies, 2024 |
10.2 France Malaria Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here